Johnson & Johnson (JNJ)

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Industry: Pharmaceutical Preparations (SIC 2834)

Market region: US

Address: One Johnson & Johnson Plz, New Brunswick, NJ, 08933

Market capitalization

657.68 billion USD (657,677,164,671 USD)

Listing date

09/25/1944

Weighted shares outstanding

2,407,310,266

Share class shares outstanding

2,407,310,266

https://www.jnj.com